Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

TerminatedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Breast Cancer
Interventions
PROCEDURE

Core Biopsy

biopsy

PROCEDURE

Blood Collection

Blood/serum sample

DRUG

Paclitaxel

Paclitaxel 90 mg/m2 IV, day 1, 8 and 15

DRUG

Avastin

Avastin 10 mg/kg IV, day 1 and 15

Trial Locations (4)

46202

Indiana University Simon Cancer Center, Indianapolis

47403

Cancer Care Center of Southern Indiana, Bloomington

47905

Horizon Oncology Center, Lafayette

77030

Baylor College of Medicine - Methodist Breast Center, Houston

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Indiana University School of Medicine

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

Baylor University

OTHER

collaborator

McGill University

OTHER

lead

Hoosier Cancer Research Network

OTHER